These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35092543)

  • 1. Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic.
    Sparaco M; Miele G; Lavorgna L; Abbadessa G; Bonavita S
    Neurol Sci; 2022 May; 43(5):2935-2942. PubMed ID: 35092543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychological impact of the COVID-19 pandemic on people with multiple sclerosis.
    Vacaras V; Nistor C; Schiopu AM; Vacaras C; Marin GE; Muresanu DF
    Mult Scler Relat Disord; 2023 Aug; 76():104825. PubMed ID: 37320938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study.
    Alirezaei M; Eskandarieh S; Sahraian MA; Naser Moghadasi A
    Neurol Sci; 2022 Jan; 43(1):59-66. PubMed ID: 34554334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation.
    Mariottini A; Lotti A; Innocenti C; Repice AM; Nozzoli C; Boncompagni R; Fainardi E; Saccardi R; Massacesi L
    Eur J Neurol; 2023 Oct; 30(10):3362-3366. PubMed ID: 37483174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic.
    Bonavita S; Sparaco M; Russo A; Borriello G; Lavorgna L
    Eur J Neurol; 2021 Oct; 28(10):3396-3402. PubMed ID: 33368849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fear of COVID-19, problems accessing medical appointments, and subjective experience of disease progression, predict anxiety and depression reactions in patients with Multiple Sclerosis.
    Broche-Pérez Y; Jiménez-Morales RM; Monasterio-Ramos LO; Vázquez-Gómez LA; Fernández-Fleites Z
    Mult Scler Relat Disord; 2021 Aug; 53():103070. PubMed ID: 34119745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis.
    Altieri M; Capuano R; Bisecco A; d'Ambrosio A; Buonanno D; Tedeschi G; Santangelo G; Gallo A
    Mult Scler Relat Disord; 2022 May; 61():103774. PubMed ID: 35381533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic and clinical factors associated with depression, anxiety, and general mental health in people with multiple sclerosis during the COVID-19 pandemic.
    Uhr L; Rice DR; Mateen FJ
    Mult Scler Relat Disord; 2021 Nov; 56():103327. PubMed ID: 34666242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
    Iaffaldano P; Lucisano G; Manni A; Paolicelli D; Patti F; Capobianco M; Brescia Morra V; Sola P; Pesci I; Lus G; De Luca G; Lugaresi A; Cavalla P; Montepietra S; Maniscalco GT; Granella F; Ragonese P; Vianello M; Brambilla L; Totaro R; Toscano S; Malucchi S; Petracca M; Moiola L; Ferraro D; Lepore V; Mosconi P; Ponzio M; Tedeschi G; Comi G; Battaglia MA; Filippi M; Amato MP; Trojano M;
    Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35046084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review.
    Zarghami A; Hussain MA; Campbell JA; Ezegbe C; van der Mei I; Taylor BV; Claflin SB
    Mult Scler Relat Disord; 2022 Mar; 59():103562. PubMed ID: 35149393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic.
    Yeni K; Tulek Z; Terzi M
    Mult Scler Relat Disord; 2022 Jan; 57():103370. PubMed ID: 35158434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
    Etemadifar M; Sedaghat N; Aghababaee A; Kargaran PK; Maracy MR; Ganjalikhani-Hakemi M; Rayani M; Abhari AP; Khorvash R; Salari M; Nouri H
    Mult Scler Relat Disord; 2021 Jun; 51():102915. PubMed ID: 33799284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage.
    Shaygannejad V; Mirmosayyeb O; Nehzat N; Ghajarzadeh M
    Neurol Sci; 2021 Jul; 42(7):2615-2618. PubMed ID: 33860396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping with stress during the first wave of the COVID-19 pandemic by Turkish people with Multiple Sclerosis: The relationship between perceived stress and quality of life.
    Altunan B; Unal A; Bingöl A; Dilek F; Girgin D
    Mult Scler Relat Disord; 2021 Aug; 53():103039. PubMed ID: 34087686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
    Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
    Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience.
    Zanghì A; D'Amico E; Luca M; Ciaorella M; Basile L; Patti F
    Mult Scler Relat Disord; 2020 Nov; 46():102561. PubMed ID: 33045494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population.
    Ramezani N; Ashtari F; Bastami EA; Ghaderi K; Hosseini SM; Naeini MK; Rajabi F; Adibi I
    Mult Scler Relat Disord; 2021 May; 50():102798. PubMed ID: 33571791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surviving a global pandemic: The experience of depression, anxiety, and loneliness among individuals with multiple sclerosis.
    Strober L; Weber E; Lequerica A; Chiaravalloti N
    Mult Scler Relat Disord; 2022 Feb; 58():103497. PubMed ID: 35066271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study.
    Feinstein A; Amato MP; Brichetto G; Chataway J; Chiaravalloti ND; Cutter G; Dalgas U; DeLuca J; Farrell R; Feys P; Filippi M; Freeman J; Inglese M; Meza C; Motl RW; Rocca MA; Sandroff BM; Salter A;
    J Neurol; 2022 Dec; 269(12):6202-6210. PubMed ID: 35939096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register.
    Garjani A; Hunter R; Law GR; Middleton RM; Tuite-Dalton KA; Dobson R; Ford DV; Hughes S; Pearson OR; Rog D; Tallantyre EC; Nicholas R; Morriss R; Evangelou N; das Nair R
    Mult Scler; 2022 Jun; 28(7):1060-1071. PubMed ID: 34080892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.